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Abstract
Objective:  The Hippo pathway plays an important role in embryo development, and separation of trophectoderm 
(TE) and inner cell mass (ICM) cell lines. Therefore, this study investigated effect of maternal age on activity of Hippo 
pathway in human embryos.  
Materials and Methods: In this experimental study, the developed up embryos to the blastocyst stage and the 
embryos whose growth stopped at the morula stage were collected from women aged 20-30 years old (young group, 
94 embryos) and >37 years (old group, 89 embryos). Expression of OCT4, SOX2, CDX2, GATA3, YAP genes and the 
relevant proteins, in the both groups were evaluated using respectively quantitative reverse transcription-polymerase 
chain reaction (qRT-PCR) and immunofluorescence methods. 
Results: There was no significant difference in the expression level of OCT4, SOX2, CDX2, GATA3 and YAP genes in 
blastocyst and morula stages, between the two groups. However, SOX2 and CDX2 gene expressions in morula stage 
embryos of the old group was statistically lower than that of the young group (P=0.007 and P=0.008, respectively). 
Additionally, in the embryos collected from women with >37 years of age, at the blastocyst stage, phospho-YAP (p-YAP) 
protein was found to be accumulated in the TE, but it was almost disappeared from the ICM. Additionally, in the old 
group, contrary to the expectation, YAP protein was expressed in the ICM, rather than TE. 
Conclusion: The results of this study showed that YAP and P-YAP among the Hippo signalling pathway may be altered 
by increasing age. 
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Introduction
Pre-implantation development starts from fertilization and 
continues with repeated divisions. It leads to the formation 
of a complex structure called blastocyst (1, 2). The major 
developmental events are embryo cleavage, compaction 
and polarization, trophectoderm/inner cell mass (ICM) 
specification and blastocyst formation with two different 
cell lines (3, 4). Trophectoderm (TE) plays an important 
role in  implantation as it interacts with the mother’s uterus 
and participates in the formation of placenta (5). After 
implantation, ICM forms three germ layers, ultimately 
generating all tissues of the body (6, 7). Several mechanisms 
including FGF, Erk/Mapk and Hippo signalling pathways are 
involved in this differentiation process (8, 9). Hippo signalling 
pathway, along with the inside-outside axis of embryo, 
regulates cell-fate switch by modulating transcription factor 
Tead4 activity (10, 11). While Tead4 is active in outside-cells 
and promotes TE development, it is suppressed in inside-cells 
by cell contact- and phosphorylation-mediated inhibition of 
nuclear localization of the Tead4 coactivator Yes-associated 
protein (YAP) (12-14). 
In the outer cells of embryo, Hippo signalling is likely 
suppressed by another signal which is produced by the cell 
polarity. YAP is translocated to the nucleus, where it increases 
CDX2 and GATA3 gene expressions together with TEAD4, 
which in turn induces trophoblast formation and OCT4 down-
regulation (12, 13, 15). In the ICM, where Hippo signalling 
is active, YAP is phosphorylated by LATS. Therefore, YAP 
remains in the cytoplasm. In the absence of a nuclear YAP, 
since TEAD4 remains inactive, CDX2 and GATA3 genes are 
not expressed and the initial expression of OCT4 is maintained 
(16, 17). Many factors -such as culture medium, oxygen 
concentration, developmental stage and age- can affect 
developmental gene expression and likely Hippo signalling 
pathway. Mantikou et al. (18) in 2015 investigated the effect 
of women’s age on gene expression in three groups of ≤35, 
36-38, and ≥39  years old. The results showed significant 
differences between the three groups. Since the expression 
of developmental genes are under the control of various 
signalling pathways, in this study, effect of women’s age on 
activity of the Hippo signalling pathway was investigated. 
According to a previous study performed by Bellieni et al. 
(19) in 2016, the woman’s optimal age for reproduction is 20-
30 years, regarding that the number of oocytes is decreased
in women after ≥35 years of age. In the present study, due
to the importance of Hippo signaling pathway in the embryo
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development, and separating TE and ICM cell lines, effect of 
women’s age on Hippo signalling pathway activity of human 
embryos was investigated.
Materials and Methods 
This experimental study was in accordance with the 
Declaration of Helsinki, following the approval of Ethical 
Committee of Royan Institute (Tehran, Iran; approval 
number: IR.ACECR.ROYAN.REC.1395.8). The patients 
were selected based on age, body mass index (BMI), cause 
of infertility, type of control ovarian stimulation (agonist and 
antagonist), Number of in vitro fertilization/intracytoplasmic 
sperm injection (IVF/ICSI) procedure as well as the oocyte 
and embryo quality, ovarian reserve and number of treatment 
cycles.  Inclusion criteria for the study encompass the quality 
of embryo, women’s age and lack of genetic diseases. 
Exclusion criteria include embryos of the patients which 
were not developed to morula and blastocyst stages.  Fresh 
and frozen embryos from consenting couples attending 
Royan Institute for infertility treatment (after signing written 
consent) were cultured in G1V5
TM medium (Vitrolife, Sweden) 
for three days, before transferring to the G2V5
TM medium 
(Vitrolife). The embryos (either those stopped at the morula 
stage or those reaching the blastocyst stage) were collected 
on day 5 and divided into two groups:  the embryos collected 
from women aged 20-30 (young group) and the embryos 
belonging to women >37 years of age (old group). 
Gene expression analysis
Total RNA from embryos that either reached to the blastocyst 
stage or stopped at the morula stage, were extracted using the 
RNeasy micro Kit (Qiagen, Germany), before, synthesizing 
complementary DNA (cDNA) by Fermentase kit  (Germany) 
(20). PCR reaction was run as follow in a total volume of 25 
µl: master mix (10 µl, Thermo, USA), forward and reverse 
specific primers (each 1 µl), cDNA (1 µl) and nuclease free 
water (12 µl). quantitative reverse transcription polymerase 
chain reaction (qRT-PCR) protocol was carried out using 
SYBER Green (Takara, Japan) according to the following 
program: initiation step at 94˚C for 300 seconds; 35 cycles 
at 94˚C for 40 seconds followed by 60˚C for 40 seconds and 
72˚C for 40 seconds, terminated by incubating at 72˚C for 
10 seconds. For presentation of data, products specificity 
was confirmed by melt curve analysis. Then, the qRT-PCR 
results were estimated using 2-ΔΔCt formula. Gene expression 
analysis was performed for pluripotency markers (OCT4, 
CDX2, GATA3 and SOX2) and Hippo signalling marker 
(YAP). GAPDH was considered as housekeeping gene. The 
oligonucleotide primers were designed using NCBI site, Perl 
Primer and Gene Runner software. The utilized primers in the 
present work are listed in Table 1. 
Immunocytochemical analysis
The embryos were fixed in 4% paraformaldehyde solution 
(Merck, Germany) for 15 minutes at room temperature 
and placed in 0.25% Triton X-100 (Sigma, USA) soluble in 
phosphate-buffered saline (PBS, Gibco, USA) for 30 minutes 
at room temperature. Then, the embryos were incubated with 
5% BSA in donkey serum for 60 minutes at room temperature 
to block unspecific binding of the antibodies, before being 
incubated with the following primary antibodies: OCT4 
(mouse monoclonal; Santa Cruz, USA, 1:100 dilution), 
CDX2 (Goat polyclonal IgG, Santa Cruz, USA, 1:100 
dilution), YAP (Rabbit polyclonal; Proteintech, USA, 1:100 
dilution)  or P-YAP (Rabbit polyclonal; Abcam, UK, 1:100 
dilution)  overnight at 4˚C, as previously described (6). 
Incubation was continued with conjugated donkey anti-
rabbit IgG (Invitrogen, USA, 1:600 dilution) for YAP 
and P-YAP, donkey anti-mouse IgG (Invitrogen, USA, 
1:600 dilution) for OCT4 and donkey anti-goat IgG 
(Invitrogen; 1:600 dilution) for CDX2 for one hour at 
room temperature. Nuclei were stained with 1 µg/ml 
4’,6-diamidino-2-phenylindole (DAPI, Sigma, USA) for 
5 minutes. For negative control, the samples were only 
treated with the secondary antibodies. All images were 
acquired by a camera (Eclipse 50i, Nikon, Japan) coupled 
to a fluorescence microscope (21). Then, the Image J 
software (V1.515) was utilized to evaluate, based on the 
intensity and the results which turned to be quantitative.
Table 1: Primers used for quantitative reverse transcription-polymerase chain reaction
Gene Primer sequencing (5´-3´) Product size
YAP F: TAGCCCTGCGTAGCCAGTTA 177
R: TCATGCTTAGTCCACTGTCTGT
CDX2 F: GCAGAGCAAAGGAGAGAGGAAA 136
R: AAGGGCTCTGGGACACTTCT
SOX2 F: GGGAAATGGAAGGGGTGCAAAAGA 151
R: TTGCGTGAGTGTGGATGGGATTGGT
OCT4 F: CTGGGTTGATCCTCGGACCT 128
R: CACAGAACTCATACGGCGGG
GATA3 F: CCTCATTAAGCCCAAGCGA 185
R: TGCCTTCCTTCTTCATAGTCAG
GAPDH F: CTCATTTCCTGGTATGACAACGA 119
R: CTTCCTGTGCTCTTGCT
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Statistical analysis
All experiments were performed using four 
independent biological replicates. Data were analysed 
using t test (for gene expression evaluation), chi-square 
(for protein expression and demographic information), 
or Mann Whitney tests (for comparison of the cycle 
numbers) using the SPSS statistical software (Ver. 
16.0, IBM, USA). Differences were considered 
significant at P<0.05.
 Table 2: Patient characteristics in the young and old groups
Patient characteristics Young Old Significance
n=34 n=20 P value
Number of male factor 14 (45) 9 (45) -
Number of female factor 1 (2) 0 -
Number of male and female fact 5 (14) 2 (5) -
Number of  recurrent abortion 1 (2) 2 (1) -
Number of thalassemia 2 (8) 0 -
Number of sex determination 4 (11) 0 -
Number of unexplained 7 (17) 7 (35) -
Number of agonist protocol 31 (91) 15 (75) -
Number of antagonist protocol 3 (8) 5 (25) -
Number of ICSI 19 (55) 8 (40) -
Number of ICSI+IVF 15 (44) 12 (60) -
Number of morula 38 17 -
Number of early blastocyst 10 8 -
Number of mid blastocyst 9 9 -
Number of expand blastocyst 18 8 -
Number of hatching blastocyst 7 3 -
Number of total oocyte 18.2 ± 7 11.6  ± 7 0.001
Number of GV 1.88 ± 1 2.44 ± 2 -
Number of Ml 1.44 ± 0.8 1.90 ± 1 -
Number of Mll 14.8 ± 7 8.76 ± 4 0.001
Mean BMI (Kg/m2) 26 ± 3 26.25 ± 4 -
Mean number of cycle 1.27 ± 0.5 2.55 ± 1.7 0.001
Female age (Y) 27 ± 2 38 ± 2 0.000
Male age (Y) 34 ± 1 42 ± 1 0.000
Data are presented as n (%) or mean ± SD. Significantly different at P<0.05. ICSI; Intracytoplasmic sperm injection, IVF; In vitro fertilization, GV; Germinal 
vesicle, MI; Metaphase I, MII; Metaphase II, and BMI; Body mass index.
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Results
Patient demographic information
Table 2 shows that demographic information of the 
participants, total number of oocytes as well as MII oocytes 
in the young group was significantly higher than that of the 
old group (P<0.05). On the other hand, number of cycles in 
the young group was significantly lower than that of the old 
group (P<0.05). Additionally, mean age of the participants in 
these groups was significantly different (P<0.05). Based on 
the demographic data, it seems that ovarian resources begin 
to decline in women with >37 years of age. 
Quantitative reverse transcription-polymerase chain 
reaction analysis 
There was no significant difference between these two 
groups, in the expression of Hippo signaling marker (YAP) 
and pluripotency genes (OCT4 and GATA3) at the Morula 
stage. However, SOX2 and CDX2 genes at the Morula stage 
had significantly higher expression levels in the young 
group, compared to the old group (P<0.05, Fig.1).
Fig.1: YAP, SOX2, OCT4, CDX2 and GATA3 gene expression levels in morula 
stage of the two groups. Data are presented as mean ± SE. *; Significant 
difference at P<0.05.
There was no difference between these groups, in the 
expression of genes (OCT4, CDX2, SOX2, GATA3 and 
YAP) at the blastocyst stage (Fig.2).
Fig.2: YAP, SOX2, OCT4, CDX2 and GATA3 gene expression levels in 
blastocyst stage of the two groups. Data are presented as mean ± SE.
Immunocytochemical analysis
Protein expression of OCT4, CDX2, YAP and phospho-
YAP (p-YAP) at the blastocyst stage did not show 
significant variation, by comparing the young and old 
groups (Table 3). 
In the old group, at the blastocyst stage, P-YAP 
protein was found to be accumulated in the TE, but it 
was almost disappeared from the ICM. Additionally, 
contrary to the expectations, in the old group, YAP 
protein was expressed in the ICM rather than TE 
(Fig.3). 
Table 3: Expression intensity of CDX2, OCT4, YAP and P-YAP proteins in the young and old groups
Proteins Young group Old group 
OCT4 CDX2 19.4 ± 2 22.1 ± 4 12.2 ± 5 10.4 ± 5
OCT4 YAP 31.8 ± 5 34.5 ± 3 13.8 ± 3 31 ± 2
OCT4 P-YAP 15.4 ± 1 35.4 ± 9 20.7 ± 4 24.9 ± 3
CDX2 YAP 41.6 ± 6 13.3 ± 1 30.18 ± 6 16.3 ± 2
CDX2 P-YAP 16.1 ± 2 24.3 ± 2 17.7 ± 6 27.7 ± 5
The data was evaluated based on the intensity. The signal intensities were quantified using Image J analysis software (V1.515). Data are presented as 
mean ± SD.   
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Fig.3: Immunofluorescence staining of developmental proteins (OCT4, CDX2, YAP and P-YAP) at the blastocyst stage. A. DAPI staining, immunofluorescence 
staining of CDX2 and OCT4 in the same cells as well as the merged DAPI and primary antibody-secondary antibody-FITC staining of CDX2 and OCT4 in 
blastocyst. B. DAPI staining, immunofluorescence staining of YAP and OCT4 in the same cells as well as the merged DAPI and primary antibody-secondary 
antibody-FITC staining of YAP and OCT4 in blastocyst. C. DAPI staining, immunofluorescence staining of P-YAP and OCT4 in the same cells as well as the 
merged DAPI and primary antibody-secondary antibody-FITC staining of P-YAP and OCT4 in blastocyst. D. DAPI staining, immunofluorescence staining of 
CDX2 and YAP in the same cells as well as the merged DAPI and primary antibody-secondary antibody-FITC staining of CDX2 and YAP in blastocyst. E. DAPI 
staining, immunofluorescence staining of CDX2 and P-YAP in the same cells as well as the merged DAPI and primary antibody-secondary antibody-FITC 
staining of CDX2 and P-YAP in blastocyst. ICM localization was distinguished by a circle (scale bars: 200 μm). 
Discussion 
During differentiation of the blastomeres, cell polarity 
and position govern formation of TE and ICM (22). This 
process is mediated by various signalling pathways, such 
as Hippo signalling pathway which is the main regulator 
of cell growth, proliferation, differentiation and death 
(9, 14). In 2013, Lorthongpanich et al. (23) reported that 
inhibition of the components of Hippo signaling pathway 
disrupted the blastomeres differentiation into ICM. After 
LATS kinase decrease, they observed that SOX2 and 
OCT4 genes (ICM genes) were significantly reduced. 
On this basis, it can be said that Hippo pathway plays 
an important role in the early embryo differentiation by 
affecting these gene. Moreover, in they showed that SOX2 
and CDX2 genes play an important role in development 
of embryos. CDX2 gene is necessary for gastrulation. 
The mutation in this gene disturbs WNT, FGF and Hippo 
signalling. SOX2 is initially expressed in the most of cells 
during morula stage. But, in the blastocyst stage, it is only 
expressed in ICM. Various factors can affect the embryo 
development from a zygote to a blastocyst, including 
quality of gametes, type of culture medium and oxygen 
concentration, as well as women’s age. 
The infertility problems in 10% of women are associated 
with higher ages. As mentioned in the introduction, 
the best reproductive age for women is 20-30 years 
and women with >35 years show decrement of fertility 
potentiality (19). A study performed by Tehraninezhad 
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et al. (24) in 2016, suggested age, as the most important 
underlying cause of infertility in women. Many of the 
infertility problems observed in older women are due to 
reduced ovarian reserve, producing fewer oocytes with 
lower quality. Several factors may reduce ovarian reserve, 
but one of the most important factors is the women‘s age. 
In this study, interesting results in terms of the expression 
of proteins were obtained by immunofluorescence 
staining. The location of YAP and the expression levels 
of P-YAP protein in the blastocyst embryos of the older 
group were not appropriate. In the older group, YAP 
protein expression was observed in TE cells, whereas 
in the blastocyst of women aged 20-30 years old, YAP 
was expressed in ICM. Furthermore, contrary to the 
expectation, expression of P-YAP in blastocyst collected 
from women aged >37 years old was observed in both 
ICM and TE cells. Therefore, with the age increase, it 
seems that Hippo pathway proteins are removed from 
their appropriate locations. According to the study 
performed by Hartley et al. (25) in 2015, if the protein 
processing step is not correctly taken after translation, 
the protein may be degraded by endopeptidase, thus 
negatively affecting the function or location of protein. 
To the best of our knowledge, there is no information 
in literature, regarding the gene expression of Hippo 
signaling pathway and its relationship with the women’s 
age in human embryo. In 2015, Li et al. (20) explored the 
Hippo signaling pathway and expression of MVH/OCT4 
genes in the mouse ovarian cortex. The level LATS2, 
MST1, MVH and OCT4 were significantly decreased with 
increasing the age. YAP was also observed in the ovarian 
cortex of two-months old, but not 20-months old mice. 
In addition, YAP phosphorylation was found in ovarian 
cortex of seven-days old compared to 20-months old mice. 
Moreover, the amount of P-YAP/YAP was decreased, as 
7-days old mice grew to 20 months. These results show 
that expressions of Hippo signaling pathway proteins are 
altered with increasing the age of ovary. A study performed 
by Pelissier et al. (21) in 2014 was conducted on breast 
epithelial progenitor cells  and showed that biochemical, 
molecular and functional phenotypes differed before and 
after menopause. Moreover, Hippo pathway dysregulation 
affects differentiation and specificity of the cells. In 
previous studies, the expression of developmental and 
Hippo signaling pathway genes at the pre-implantation 
stage was decreased with increasing age in women. In 
the present study, no significant difference was observed 
in the expression of genes between these two groups, 
but immunofluorescent results showed that expression 
level of Hippo pathway proteins might be changed with 
increasing age. 
This study has a few shortcomings which need to be 
considered in future studies. Our aim was to compare 
the gene expression of both young and old groups in 
two stages of morula and blastocyst, which required the 
same morphology. For this reason and according to the 
previous articles which have been done, total mRNA was 
extracted (23).
Conclusion
The result of this study showed that although the levels 
of YAP and P-YAP gene expression were not significantly 
different between young and old groups, in blastocyst 
stage, P-YAP protein was found to be accumulated in the 
TE and it was almost disappeared from ICM. Contrary 
to expectations, in the old (women with more than 37 
years old) group, YAP protein expression was expressed 
in ICM rather than TE. These data may indicate the 
inappropriate functionality of Hippo signaling pathway 
at the advanced ages. More accurate results could be 
obtained, if immunestaining was performed for all four 
proteins in the embryo. 
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